Viral Clearance

Nov 01, 2018
BioPharm International
The second half of this article describes the testing methods used by the authors to demonstrate the applicability of single-use mixing technology for virus inactivation.
Oct 01, 2018
BioPharm International
This article explores the use of single-use mixing technology in a detergent-based virus inactivation step during a monoclonal antibody production process.
Sep 28, 2018
BioPharm International
Testing demonstrates an automated semi-continuous process strategy for viral inactivation with steps that mimic batch processing.
Sep 01, 2018
BioPharm International
Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed.
Jun 28, 2018
By BioPharm International Editors
The new resin used a combination of “jetting” technology and a high-performance Protein A ligand.
May 01, 2018
BioPharm International
Process understanding and careful assessment of risks are essential in developing viral clearance programs.
Oct 01, 2017
BioPharm International
This study outlines methods for an alternative protein-polishing process for challenging proteins.
Oct 01, 2017
BioPharm International
Detecting viral contaminants in biologic-based medicines—and identifying their source—requires a holistic testing approach.
Sep 15, 2017
BioPharm International
A case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Sep 01, 2017
BioPharm International
Protecting against microbiological contamination over the whole manufacturing process grows increasingly important.
native1_300x100
lorem ipsum